ABSTRACT The entire sequences of the variable region of four heavy chains from BALB/c inulin-binding myeloma proteins have been determined. Among the four proteins there are six amino acid differences, all of which occur in the framework portion of the variable region. All of the six amino acid substitutions can be explained by single base mutations at the DNA level. The pattern of diversity in these proteins is compared to a previously reported group of heavy chains from phosphorylcholine-binding myeloma proteins. Unlike the phosphorylcholine-binding proteins, which(with the exception of two that are identical) have size and sequence differences in their complementarity regions, the inulin-binding heavy chains all have identical complementarity regions with H3 being extremely short. The pattern of variation observed in the anti-inulin heavy chains appears to be most easily explained by a somatic mutation mechanism. However, because none of the substitutions occur in complementarity-determining regions, they presumably would have no selective advantage and would not after binding specificity. These proteins have further been shown to have crossreacting antigenic determinants (idiotypes). Five of the six sequence differences observed occur at positions that are internal in the molecule and thus presumably would not account for the idiotypic differences. These results suggest that most of the observed idiotypic crossreactivities will be due to differences in the light chains of the anti-inulin proteins.
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Mouse myeloma proteins have been used in recent years as models to study many interesting aspects of the immune system, in particular those associated with the structure of the antibody molecule itself (1) (2) (3) (4) (5) (6) (7) . These studies have supplied valuable information in areas such as antibody diversity, antibody threedimensional structure, and idiotypy. Analysis of groups of proteins that bind the same haptenic determinants is particularly useful as a means of assessing patterns of variation among proteins with similar binding specificities.
To date, extensive primary structural data have been obtained on the variable regions of the heavy chains from seven phosphorylcholine-binding proteins (refs. 6, 8 , and 9; unpublished data). Two of these proteins (T15 and S107) are identical throughout their entire variable regions. All of the proteins, with the exception of M167 and M511, have identical framework portions of the variable region and, with the exception of the two identical chains, all have sequence and size differences in the complementarity regions. Among these seven heavy chains, four different lengths are found in the third complementarity region. If these structures were to be generated from a single germ-line sequence by somatic mutation, then insertion or deletion must be a relatively common mutational event (three out of seven occurrences). In addition, the observation of amino acid substitutions in the framework as well as complementarity regions would suggest that somatic mutation is not limited to complementarity regions. Alternatively, these sequences could be generated by several closely related genes contained in the germ line. If this were in fact the case and other antigen-binding specificities were represented by several germ-line genes, then the number of genes coding for the antibody repertoire would be correspondingly large. The question arising is, "Does this type of variation seen in the phosphorylcholine system occur in other proteins with similar hapten binding specificities and thus are the genetic implications generally applicable?"
A second group of myeloma proteins with binding specificity for inulin has recently been investigated to provide a basis for a comparison with the anti-phosphorylcholine proteins (10) (11) (12) . These proteins demonstrate specificity for oligosaccharides containing 2--linked f-D-fructofuranoside residues terminated by a 2-1-linked a-D-glucopyranose moiety (13) . The combining sites of two of these proteins, A4 and A47N, show highest complementarity for a trifructofuranosyl unit and two others, U61 and E109, for a tetrafructofuranosyl sequence. The association constants of these four proteins for the tetrafructofuranoside range from 1.1 to 4.0 X 105 M-1.
In the present communication we report the complete sequences of the variable region from the heavy chains of three of these proteins, E109, A4, and U61. The variable region sequence of the fourth inulin-binding protein, A47N, has been described (14) . The pattern of variation observed in the antiinulin system is compared to that noted in the heavy chains of the phosphorylcholine-binding proteins. In addition, the 11 inulin-binding proteins described to date have been shown to possess crossreacting as well as individual idiotypes* (10). Thus, the primary sequence data presented here may begin to elucidate the structural basis of idiotypy in these proteins.
MATERIALS AND METHODS
Protein Purification. E109, A4, and U61 IgA, K myeloma proteins were purified by affinity chromatography on Sepharose-inulin columns as described (11) .
Heavy Chain Preparation. After dialysis against 0.15 M Tris-HCI/0.15 M NaCl/2 mM Na2EDTA, the proteins were reduced with 10 mM dithiothreitol, alkylated with 20 mM iodoacetamide (15) , and dialyzed overnight against 6 M urea/i M acetic acid. Heavy and light chains were separated by chromatography on a Sephadex G-100 column equilibrated in 6 The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact.
Sequence Determination. Intact heavy chains and appropriate purified CNBr fragments were subjected to automated degradation on a Beckman 890C sequencer using the standard dimethylallylamine (DMAA) program with two modifications (14) . (i) An additional 2-sec delivery of coupling buffer was performed after the initial coupling reaction. (fi) Benzene and ethyl acetate were delivered simultaneously for 200 sec after coupling. Phenylthiohydantoin derivatives were identified by gas chromatography (16) and two-dimensional thin-layer chromatography (17) . HI acid hydrolysis products of the derivatives (18) were identified on a Beckman 119 amino acid analyzer. All derivatives were initially analyzed by gas chromatography. Positions not identified by gas chromatography were examined by thin-layer chromatography and amino acid analysis. In addition, all positions in the latter portion of sequencer runs were hydrolyzed and subjected to amino acid analysis.
When necessary, certain CNBr fragments were digested with trypsin (1:50) at 370 for 5 hr in their native state or after citraconylation. The peptide containing homoserine at its COOH terminus was then coupled to triethylenetetramine resin (19) and its sequence was determined on a Sequemat model 12 solid-phase sequencer.
Citraconylation. Protein was dissolved in 0.5 M borate buffer (pH 8.2) and a 25-fold molar excess (over lysine residues) of citraconic anhydride was added. The mixture was incubated at room temperature for 45 min and then dialyzed against 0.02 M ammonium bicarbonate.
RESULTS
CNBr Fragments and Sequence Determination. Procedures for the isolation and sequencing of CNBr fragments from all three heavy chains were identical to those reported for A-47N (14) and will be described for only one of the proteins.
Heavy chains were cleaved with CNBr and chromatographed on a Sephadex G-100 column as described in Fig. 1 upper. Cn-1 was then completely reduced, alkylated with [14C]iodoacetamide, and chromatographed on the same Sephadex G-100 column ( Fig. 1 lower) .
The sequence of the NH2-terminal 37 residues of each protein was determined by automated degradation of intact heavy chains. Fragment Cnl-A has been reported as a large peptide from the constant region (8) . Cnl-C is a variable region fragment beginning at position 84 and was sequenced to position 116, the beginning of the constant region ( The first of these systems to be analyzed in detail was mouse Xl chains. Eighteen of these chains have been studied to date (1, 20) , of which 11 have identical sequences. The remaining seven differ from the common sequence by no more than three amino acids and all substitutions occur in complementaritydetermining or hypervariable segments. This observation was interpreted as indicating that all of the Xl sequences were derived from a single germ-line gene and that the variants arose by somatic mutation limited to complementarity-determining regions. Presumably, the amino acid substitutions in the variants would alter the binding specificity, and new antigens could then select and expand these clones. This interpretation has been supported by nucleic acid hybridization studies (21, 22) which also suggest a small number of X germ-line genes, although considerable controversy exists as to the ability of this technique to measure gene numbers accurately.
A second system being investigated, mouse K chains, appears to be considerably more complicated than the Xl system de- 100 110 At present, several theories have been proposed to account for antibody diversity. The three most widely subscribed to are somatic (25) , germ line (26) , and insertional (27, 28) models. It is interesting to assess the anti-inulin sequences in terms of these models. The first hypothesis, the somatic mutation model, would suggest that the observed sequence differences are the result of somatic mutation occurring on a single germ-line gene. This interpretation appears quite plausible, especially in that none of the amino acid interchanges in the four chains is repeated in a second chain and that all of the changes can be accounted for by single base changes at the DNA level in the ABE-4 prototype. However, if these structures were generated by somatic mutation, this event must occur at a higher frequency in the framework segments than in complementaritydetermining segments in this system, in complete contrast to the mouse A system of Weigert et al. (1) . The substitutions in the anti-inulin heavy chains suggest that if they are somatic in origin then this mutational process is not limited to complementarity-determining segments. If this is the case, it should be expected that similar variation would also be found in the constant regions of immunoglobulins. Although no detailed analyses are available on constant regions from inbred populations, studies on human A chains have disclosed variations at 12 positions in the A chain constant region (29, 30) . Most of these studies involved the identification of variants by observing peptides with charge differences compared to a prototype structure. Substitutions that did not produce charge differences-Le., leucine for valine-would not be detected and thus Immunology: Vrana et al.
Proc. Nati. Acad. Sci. USA 75 (1978) the total number of substitutions may be considerably larger than 12. Although these variations could clearly result from polymorphism in the human population, they are the same types of substitutions that might be expected from a random somatic mutation process. It is also important to note that the substitutions in the anti-inulin heavy chains are all in the framework and could not be selected for by antigen because they are located in positions that would not contribute to antigen binding (see below).
The second hypothesis of diversity, the germ-line model, would suggest that the anti-inulin heavy chains are coded for by several genes that probably arose by duplication and are contained in the germ line. This argument would be based on the following analysis. At position 48, valine is found in three of the proteins and isoleucine in the fourth. If one examines all available heavy chain sequences (31) , it can be observed that only four different amino acids have been found at this position-isoleucine, valine, leucine, and methionine, each occurring 17 (44%), 15 (38%), 6 (15%), and 1 (3%) time, respectively. Thus, the isoleucine, which occurs in only one of the anti-inulin proteins, is in fact the most common amino acid at this position in all other heavy chains and must be considered as a possible chemical marker for another VH framework. A similar assessment can be made for position 92 at which glycine occurs in three of the proteins and alanine in the fourth. Of 41 heavy chains sequenced in this area, alanine occurs 38 times and glycine 3 times. At position 80, tyrosine is the most commonly seen amino acid (21 occurrences), with phenylalanine having been found four times in addition to four other amino acids. The other framework interchanges in these proteins are unique. If the three interchanges that occur at high frequency in other heavy chains represent markers for additional germ-line framework genes, at least three genes would be required to code for these chains. If other systems exhibited a similar diversity, the total number of germ-line genes required would be extremely large. It should be noted that the substitutions discussed above, regardless of their origin (somatic or germ-line), appear to be nonrandom in that only limited alternatives can be found at any given position. This observation may reflect the possibility that any other amino acids occurring at a given position would not permit proper folding and would result in a nonfunctional molecule.
The third hypothesis, the insertional model, suggests that complementarity-region sequences are coded by separate genes that are inserted into framework gene sequences, with selection occurring at the level of complementarity regions. If the diversity of anti-inulin heavy chains followed this model, then one should expect to see the same complementarity regions associated with quite different framework sequences, which is not the case (Table 1) . Identical complementarity regions are always associated with frameworks that do not vary by more than a few amino acids. An alternative for this model would be to propose that selection also occurs at the framework level so that the same complementarity regions are regularly paired with extremely similar framework sequences. Relative to this point is the observation of a similar association of complementarity regions and frameworks in the light chains from BALB/c myelomas and induced anti-phosphorylcholine antibodies. Light chains from several of the BALB/c myelomas that bind phosphorylcholine belong to different subgroups having quite unrelated sequences in both the NH2-terminal framework segment and the first complementarity region (32) . Sequence analysis of light chains from anti-phosphorylcholine antibodies induced in A/J mice (33) have revealed the same framework segments and the same complementarity regions as are seen in the BALB/c proteins. Based on an insertional model, it would thus be necessary for these two strains to have independently acquired the same genes -for both complementarity and framework segments and to insert them in an identical fashion. It appears that the mechanism necessary to select both complementarity regions and frameworks and to insert the proper complementarity regions in the proper order in the framework would be extremely complicated, making this model less attractive.
Although the data presented do not refute or establish any of the proposed mechanisms for generation of diversity, they do clearly begin to place important restrictions on the various models, as discussed above. The variation found in the antiinulin proteins appears to be most compatible with a somatic mechanism. If one accepts these substitutions as somatic events, the conclusion follows from the various systems examined to date that somatic mutation operates in both framework and complementarity-determining regions. Because the substitutions observed in the anti-inulin proteins do not occur in com--plementarity-determining segments and presumably could not be selected for by antigen, it is unclear how effective a mutational process operating in this manner could be in generating diversity. A random mutational process operating at the somatic level, however, could serve to make fine adjustments to antibody specificities coded for by germ-line genes.
Among the 11 inulin-binding myeloma proteins studied to date, Lieberman et al. (10) have identified crossreacting as well individual idiotypes. As a first step in approaching the structural basis of these idiotypes the question may be asked, "Could the observed differences in idiotype among these four proteins be accounted for by the amino acid differences seen in the heavy chains?" In order for an antigenic change to be effected, a difference in the surface configuration of the molecule would have to be brought about, necessitating amino acid differences either to be on the surface of the molecule or, if internal, to affect the nearby three-dimensional orientation such that the surface of the heavy or light chain is changed. By using the previously determined three-dimensional structure of M603 (4), a model of EPC-109 has been constructed (34, 35) . All of the amino acid differences in the four heavy chains are internal except for the phenylalanine in EPC-109 at position 80. The six amino acid substitutions are conservative with respect to the amino acids that they replace in that the side chains of the internal residues are not sufficiently different in size to alter the spatial orientation of nearby surface residues. In conclusion, the molecular models of these proteins would suggest that the surfaces of three of the heavy chains are identical in appearance, whereas EPC-109 is slightly different from the others with a phenylalanine replacing a tyrosine on the surface of the molecule. The structural similarities among these four heavy chains suggest that the differences in hapten inhibitible crossreacting idiotypes, presumed to be in or very near the complementarity regions, are not brought about by differences in the heavy chain. The exposed phenylalanine in EPC-109, which is far from the complementarity regions, conceivably could cause a non-hapten-inhibitible idiotypic difference, distinguishing it from the three other proteins. The three other proteins display no heavy chain subsitutions that might account for the serological differences. At this time it would seem more likely that the various idiotype differences in these proteins result from structural changes in the light chains.
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